To view this email as a web page, click here.

Conference Coverage
Were you able to attend the 2019 AAD Annual Meeting in Washington, D.C.? Visit our conference page for our highlights from the meeting.
 
New biologics target multiple dermatoses
The development of new biologics targeting a variety of dermatoses is on the upswing with some treatments coming to the clinic as early as this year, says April Armstrong, M.D. who discussed the topic at the American Academy of Dermatology Annual Meeting in Washington, D.C.
 
Patient-centered approach in psoriasis
In psoriasis, many therapies offer roughly the same level of care, but that doesn’t mean any patient will respond well to any therapy. According to Mark Lebwohl, M.D., physicians should consider each treatment option in light of each patient's specific comorbidities.
 
Managing skin disease in pregnancy
Treating chronic inflammatory skin conditions during pregnancy can be difficult because the therapies dermatologists prescribe can affect the unborn infant. Jenny Murase, M.D. offers her insights on managing chronic inflammatory skin conditions in pregnant patients.
 
For live updates from the meeting, be sure to follow us at @DermTimesNow on Twitter!
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.